Integra LifeSciences Acquires Acclarent, Inc.
April 1, 2024
Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.
- Buyers
- Integra LifeSciences Holdings Corporation
- Targets
- Acclarent, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Integra LifeSciences Acquires ACell, Inc.
December 16, 2020
Medical Devices
Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.
-
Incyte Acquires Escient Pharmaceuticals
April 23, 2024
Biotechnology
Incyte has agreed to acquire Escient Pharmaceuticals for $750 million plus Escient's net cash, adding two first‑in‑class oral MRGPR antagonists (EP262 and EP547) to its inflammation and autoimmunity portfolio. The acquisition, subject to customary closing conditions and HSR clearance, expands Incyte's pipeline in dermatology, chronic urticaria and pruritus with expected closing in 3Q 2024.
-
Montagu Acquires Stake in Intech (Orthopaedic Medical Device Manufacturer)
July 12, 2021
Medical Devices
Montagu, a European private equity firm, has entered into and closed a strategic investment in Intech, the France-based global leader in contract manufacturing of orthopaedic surgical instruments. The transaction follows negotiations with existing investors Eurazeo PME and Andera Partners and will see Montagu support Intech’s management to accelerate organic and external growth, expand capacity, and strengthen its position in orthopaedics.
-
Integra LifeSciences Acquires Surgical Innovation Associates (SIA)
December 1, 2022
Medical Devices
Integra LifeSciences agreed to acquire Surgical Innovation Associates (SIA), the developer of DuraSorb, a resorbable synthetic matrix for plastic and reconstructive (including implant-based breast) surgery. Integra will pay $50 million at closing with up to $90 million in contingent consideration to support its expansion into breast reconstruction and strengthen its soft tissue reconstruction portfolio.
-
Business Integra Technology Solutions Acquires Aquila Technology from Zensar
April 2, 2021
IT Services
Business Integra Technology Solutions has acquired Aquila Technology Corp., a wholly owned subsidiary of Zensar Technologies Inc., strengthening Business Integra’s capabilities and presence in the U.S. national security and government IT market. The deal, announced April 2, 2021, was advised by FOCUS Investment Banking and transfers Aquila’s government-focused IT and engineering services to Business Integra.
-
Smith & Nephew Acquires Integrity Orthopaedics
January 21, 2025
Medical Devices
Smith & Nephew has completed the acquisition of US-based Integrity Orthopaedics for up to $450 million, comprising an initial $225 million cash payment and up to $225 million in performance‑based payments over five years. The deal adds Integrity's FDA‑cleared Tendon Seam rotator cuff repair system to Smith & Nephew's sports medicine and shoulder portfolio to expand capabilities and accelerate growth under its RISE strategy.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.